UTP18 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.533200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.689400E-01
Normal-vs-Stage2
8.335200E-01
Normal-vs-Stage3
1.361970E-01
Normal-vs-Stage4
3.640200E-01
Stage1-vs-Stage2
7.300600E-01
Stage1-vs-Stage3
7.216200E-02
Stage1-vs-Stage4
2.880200E-01
Stage2-vs-Stage3
1.091230E-01
Stage2-vs-Stage4
1.698040E-01
Stage3-vs-Stage4
2.832100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.850200E-01
Normal-vs-AfricanAmerican
7.783400E-01
Normal-vs-Asian
1.028780E-01
Caucasian-vs-AfricanAmerican
5.151000E-01
Caucasian-vs-Asian
6.319000E-03
AfricanAmerican-vs-Asian
3.966300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.969800E-01
Normal-vs-Female
9.372200E-01
Male-vs-Female
4.826200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.016800E-01
Normal-vs-Age(41-60Yrs)
7.846800E-01
Normal-vs-Age(61-80Yrs)
6.363800E-01
Normal-vs-Age(81-100Yrs)
7.075000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.755800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.360200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.874800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.532200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.102800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.535400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.932800E-01
Normal-vs-Daily Drinker
2.734600E-01
Normal-vs-Weekly Drinker
5.737200E-01
Normal-vs-Occasional Drinker
5.327600E-01
Normal-vs-Social Drinker
7.451000E-01
Non Drinker-vs-Daily Drinker
3.590800E-01
Non Drinker-vs-Weekly Drinker
8.420800E-01
Non Drinker-vs-Occasional Drinker
1.530310E-02
Non Drinker-vs-Social Drinker
1.147810E-01
Daily Drinker-vs-Weekly Drinker
4.008400E-01
Daily Drinker-vs-Occasional Drinker
3.139000E-03
Daily Drinker-vs-Social Drinker
5.127800E-02
Weekly Drinker-vs-Occasional Drinker
5.371500E-02
Weekly Drinker-vs-Social Drinker
1.894430E-01
Occasional Drinker-vs-Social Drinker
6.847600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.778600E-01
Normal-vs-Grade 2
7.519600E-01
Normal-vs-Grade 3
7.424200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.910200E-01
Grade 1-vs-Grade 3
5.692600E-01
Grade 1-vs-Grade 4
3.778600E-01
Grade 2-vs-Grade 3
8.331200E-01
Grade 2-vs-Grade 4
7.519600E-01
Grade 3-vs-Grade 4
7.424200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.448600E-01
Normal-vs-NonDiabetic
8.836200E-01
Diabetic-vs-NonDiabetic
2.636000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.741000E-01
Normal-vs-NoPancreatitis
8.787400E-01
Pancreatitis-vs-NoPancreatitis
3.116200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.430600E-01
Normal-vs-N1
7.702800E-01
N0-vs-N1
2.152000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.148000E-01
Normal-vs-TP53-NonMutant
9.581400E-01
TP53-Mutant-vs-TP53-NonMutant
5.379800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
